Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Sep 30, 2026 · Filed Oct 28, 2026
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider buying
Bought outside the usual windowTraded Oct 14 · filed the same day
The CEO of Inhibrx Biosciences paid $210K out of pocket for Inhibrx Biosciences shares. 1 other person at Inhibrx Biosciences bought some too, in the same month.
Insider buying
Bought outside the usual windowTraded Oct 14 · filed the same day
The CEO of Inhibrx Biosciences paid $8.6K out of pocket for Inhibrx Biosciences shares. 1 other person at Inhibrx Biosciences bought some too, in the same month.
Insider buying
Bought outside the usual windowTraded Oct 14 · filed the same day
The CEO of Inhibrx Biosciences paid $208K out of pocket for Inhibrx Biosciences shares. 1 other person at Inhibrx Biosciences bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
